NEW YORK (GenomeWeb) – GenMark Diagnostics announced today that it expects to post a 7 percent increase its fourth quarter revenues on strong sales of its ePlex molecular diagnostics systems.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.